Tissue Engineered Skin Substitutes Market Size Worth $947.3 Million by 2027: Grand View Research, Inc.
SAN FRANCISCO, May 6, 2020 /PRNewswire/ -- The global tissue engineered skin substitutes market size is expected to reach USD 947.3 million by 2027, expanding at a CAGR of 4.7%, according to a new report by Grand View Research, Inc. Technological advancements, high demand for skin grafts, and rising prevalence of acute wounds are the key driving factors for the market.
Rising demand for skin grafts is a major factor boosting market growth. The recent trend of burn care and treatment has shifted to a more comprehensive approach which not only focuses on recovery from burn injury but also on improvement in long-term function and form of the healed injury and quality of life. Owing to this trend the demand for use of grafting and other substitutes in treatment and management of acute burns has increased and is rising at a constant pace.
Key suggestions from the report:
In terms of revenue, the biological segment held the market share in 2019 as the graft is prepared from patient's skin and it easily matches with the infected site
The acute wounds segment held the largest market share in 2019 as skin grafts are, generally, used in the treatment of burn injuries and surgeries. Thus, increasing prevalence of burn cases is anticipated to drive the market
The hospital segment held the largest market share in 2019 and is expected to witness the fastest growth rate over the forecast period due to the increasing number of surgeries
In Asia Pacific, the market is expected to witness the fastest growth rate over the forecast period owing to the rising prevalence of chronic and acute wounds in this region
Prominent key players present in the tissue engineered skin substitutes market are Amarantus BioScience Holdings; Organogenesis, Inc.; KCI Licensing, Inc.; Smith and Nephew; BSN medical; Mölnlycke Health Care AB; Integra LifeSciences Corporation; Medtronic; and Tissue Regenix
Read 120 page research report with ToC on "Tissue Engineered Skin Substitutes Market Size, Share & Trends Analysis Report By Product (Synthetic, Biosynthetic, Biological), By Application (Acute Wounds, Chronic Wounds), By End Use, By Region, And Segment Forecasts, 2020 - 2027" at: https://www.grandviewresearch.com/industry-analysis/tissue-engineered-skin-substitutes-market
Skin grafts are majorly used on partial and full thickness burns and have an important role in treatment of burn injuries. The grafts can be biological or synthetic in nature. Biological sources of skin grafts include cadaver skin, skin from the patient itself, and skin obtained from another donor either an allograft or xenograft. Moreover, these grafts provide more intact extracellular matrix, which aids in healing of wounds. Skin grafts allow excellent re-epithelization due to the presence of basement membrane and also show increased control over scaffold composition. It also has advantages over other dressing materials in terms of absorbency and frequency of dressing change. Aforementioned benefits are anticipated to drive the overall growth of the market.
Grand View Research has segmented the global tissue engineered skin substitutes market on the basis of product, application, end use, and region:
Surgical Navigation Systems Market ? Rising prevalence of target disorders such as osteoarthritis, brain cancer, and ENT disorders along with increasing geriatric population is expected to propel the growth.
Blood Warmers Market ? Rise in surgical procedures worldwide, along with growing incidence of road accident fatalities is anticipated to drive the market growth. Additionally, rising demand of blood warmers from ambulatory services and military/defense sectors is expected to further fuel the growth in near future.
Single Use Ophthalmic Surgical Devices Market ? Increasing in number of ophthalmic complications such as myopia, cataract, diabetic retinopathy, and others is expected to drive the single use ophthalmic surgical devices market.
Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Clarivate Plc , a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligencetm solution, featuring a new post-approval variations module. The module for post-approval variations...
Varian, a Siemens Healthineers company, will showcase its ongoing commitment to embracing innovation and enhancing outcomes for cancer care teams and their patients at this year's 2024 European Society for Radiation Oncology (ESTRO) annual meeting,...
Today, 2 May 2024, is the last day of trading in unit rights in SciBase Holding AB (publ) ("SciBase" or the "Company") rights issue of units of up to approximately SEK 15 million (the "Rights Issue"). The Rights Issue was resolved by the Board of...
SciBase Holding AB ("SciBase") (STO: SCIB), a pioneer in skin cancer detection and prevention, and prediction in dermatology, further deepens their commitment to patients and dermatologists during US Skin Cancer Awareness Month by highlighting the...
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that Dra. Beatriz Guil of Universitario de Canarias in the Canary Islands and Dr. Carlos Milliani of Universitario de Fuenlabrada in...
YourBio Health, a Boston-based pioneer in remote, capillary whole blood collection technology, congratulates Myriad Genetics for having sold one million of its leading SneakPeek® Tests. Since 2021, YourBio Health is pleased to have contributed over...